Sorafenib Impurity 9(862875-16-9)
- Name: Sorafenib Impurity 9
- Synonyms:Sorafenib Impurity 9;862875-16-9;4-(4-(3-(4-Hydroxy-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide;K4AX5J8PYE;SCHEMBL5568327;NUDOMXMCXPMNQE-UHFFFAOYSA-N;2-Pyridinecarboxamide, 4-[4-[[[[4-hydroxy-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl;4-[4-[[[[4-Hydroxy-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-[[4-hydroxy-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
- Molecular Formula:C21H17F3N4O4
- Molecular Weight:446.4
- CAS Registry Number:862875-16-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.862875-16-9 Sorafenib Impurity 9
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.862875-16-9 Sorafenib Impurity 9
Assay:95% Storage:-20 掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 208923-63-1/Irbesartan metabolite 3
- 869561-30-8/E-2110 free base
- 870783-41-8/kaempferol 7-O-(2-E-p-coumaroyl-alpha-L-rhamnopyranoside)
- 735329-10-9/Peptide antigen sura1.t
- 717102-85-7/4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- 907596-28-5/Tanurmotide
- 927182-31-8/1H-Indole-4,5,6,7-d4-3-acetonitrile
- 764724-27-8/Glutamine ethyl ester
- 887028-34-4/Mevalocidin
- 885044-44-0/Methyl 3-acetylamino-5-hydroxybenzoate
- 874098-11-0/(1S)-1-(3-nitrophenyl)propan-1-amine
- 896447-73-7/3-Amino-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxylic acid
- 77900-30-2/6-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]-4-methoxypyran-2-one
- 256950-03-5/3alpha-Hydroxy-5alpha-androstane-4,17-dione
- 887403-16-9/isoxazolidinyl-PAH
- 950980-98-0/PF-670462 free base
- 861904-37-2/Benzamide, 3-fluoro-4-methyl-5-(1-phenyl-1H-indazol-5-yl)-
- 146761-68-4/Grepafloxacin, (R)-
- 2244942-61-6/trans-4-[N-ethyl-N-(2-nitrobenzenesulfonyl)amino]-5,6-dihydro-6-methyl-4-H-thieno-[2,3-b]-thiopyran-7,7-dioxide
- 862875-16-9/Sorafenib Impurity 9
- 884340-66-3/4-(2-Aminoethyl)-3,5,6-tribromobenzene-1,2-diol hydrobromide
- 874213-55-5/Dichapetalin L
- 480462-62-2/2-(4-(2-(4-Chlorophenyl)-5-(2-oxopyrrolidin-1-yl)benzyloxy)-2-fluorophenyl)-1-cyclohexylbenzimidazole-5-carboxylic acid
- 51650-00-1/3-Methylisoxazolidine
- 894494-99-6/Unii-R6464792NG
- 882516-48-5/2-(Azidomethyl)-1,3-propanediol
- 887130-70-3/3-Chloro-1-(1-naphthalenyl)-4-phenyl-2-azetidinone
- 503610-29-5/N-(3-Oxotetradecanoyl)-DL-homoserine lactone
- 869640-83-5/N-[6-(Acetyloxy)hexyl]-4-nitrobenzenesulfonamide
- 189015-24-5/4NV3DQ8L8T